TINEA KORPORIS ET KRURIS ET FASIALIS DENGAN TERAPI KOMBINASI ANTI JAMUR

Authors

  • Diah Purnama Sari Ida Ayu Undiksha

DOI:

https://doi.org/10.23887/gm.v3i1.59579

Keywords:

antifungi, tinea, terapi, terapikombinasi

Abstract

Abstrak

Tinea atau dermatofitosis merupakan infeksi superfisial pada kulit, rambut, dan kuku yang disebabkan oleh infeksi dermatofita. Dermatofita merupakan kelompok jamur yang memiliki kemampuan untuk menggunakan keratin sebagai sumber nutrisinya, oleh karena itu dermatofita menginfeksi jaringan yang mengandung keratin seperti kulit, rambut, dan kuku. Tinea disebabkan oleh tiga kelompok jamur yakni Epidermophyton, Trichophyton, dan Microsporum. Kami melaporkan seorang wanita berusia 50 tahun yang dikonsulkan dengan keluhan gatal yang dirasakan sejak 1 tahun yang lalu. Keluhan gatal disertai dengan bintik-bintik kemerahan pada kulit, yang kemudian berubah menjadi warna putih, dan akhirnya mengelupas. Pada pemeriksaan dermatologis, didapatkan pada regio fasialis, toraks, serta kruris dekstra dan sinistra berupa makula hipopigmentasi disertai skuama, berbatas tegas sirkumskrip, tepi berwarna kemerahan, multipel, berbentuk tidak beraturan, berukuran plakat, tersusun konfluen, dan tersebar regional pada regio kruris dekstra dan sinistra. Pada pemeriksaan mikrobiologi KOH 10% kerokan kruris dekstra dan sinistra, didapatkan hasil positif jamur. Pasien terdiagnosis tinea korporis et kruris et fasialis, kemudian diberikan tatalaksana topikal berupa ketokonazol krim 2%, serta sistemik berupa itrakonazol tablet 1x200 mg dan setirizin tablet 1x10 mg.

 

Kata kunci: Tinea, Anti Fungi, Terapi, Kombinasi.

 

Abstract

Abstrak Tinea or dermatophytosis is a superficial infection of the skin, hair and nails caused by infection with dermatophytes. Dermatophytes are a group of fungi that have the ability to use keratin as a source of nutrition, therefore dermatophytes infect tissues containing keratin such as skin, hair and nails. Tinea is caused by three groups of fungi namely Epidermophyton, Trichophyton, and Microsporum. We report a 50 year old woman who was consulted with complaints of itching that was felt since 1 year ago. Complaints of itching are accompanied by reddish spots on the skin, which then turn white and eventually peel. On dermatological examination, we found hypopigmented macules with scaling, circumscribed, reddish edges, multiple, irregularly shaped, plaque-sized, confluent arranged, and spread regionally in the right and left cruris regions. left. On the microbiological examination of KOH 10% on the right and left cruris scrapings, positive results were obtained for the fungus. The patient was diagnosed with tinea corporis et cruris et facialis, then was given ketoconazole 2% cream topically, itraconazole tablets 1x200 mg and cetirizine tablets 1x10 mg.

 

Keywords : Tinea, Anti Fungi, Therapy, Combination



References

Ahmad S, Ahmad G, Mohsin M. Superficial Dermatophytic Infection Prevention and Its Management: A Review. Int J Res Rev 2021; 8: 427–439.

Brescini L, Fioriti S, Morroni G, Barchiesi. F. Antifungal combinations in dermatophytes. J Fungi 2021; 7: 1–16.

Burmana F, Putri MN, Nusadewiarti A. Penatalaksanaan dan Pencegahan Tinea Korporis pada Pasien Wanita dan Anggota Keluarga. Agromedunila 2017; 4: 103–108.

Choi FD, Juhasz MLW, Atanaskova Mesinkovska N. Topical ketoconazole: a systematic review of current dermatological applications and future developments. J Dermatolog Treat 2019; 30: 760–771.

Datt S, Datt T. Pathogenesis and Clinical Significance of Dermatophytes. Int J Curr Microbiol Appl Sci 2019; 8: 1877– 1886.

De Doncker P, Pande S, Richarz U, Garodia N. Itraconazole: What clinicians should know? Indian J Drugs Dermatology 2017; 3: 4.

Frieden IJ. Diagnosis and management of tinea capitis. Pediatr Ann 1987; 16: 39–48.

Gadithya IDG, Darmada IG., R LMM. Tinea Korporis Et Kruris. e-Jurnal Med Udayana 2015; 3: 449–462.

Hosthota A, Gowda T, Manikonda R. Clinical profile and risk factors of dermatophytoses: a hospital based study. Int J Res Dermatology 2018; 4: 508.

Jartarkar SR, Patil A, Goldust Y, Cockerell CJ, Schwartz RA, Grabbe S et al. Pathogenesis, Immunology and Management of Dermatophytosis. J Fungi 2022; 8: 1–15.

Oktaviana N, Kawilarang AP, - D. Patient Profile Of Tinea Corporis In Dr. Soetomo General Hospital, Surabaya From 2014 To 2015. J Berk Epidemiol 2018; 6: 200.

Nurindi S, Oktarlina RZ, WP RR. Terapi Farmakologis Tinea Korporis pada Anak Pharmacologic Therapy for Children with Tinea Corporis. Medula 2020; 10: 760–766.

Leung AKC, Lam JM, Leong KF, Hon KL. Tinea corporis: An updated review. Drugs Context 2020; 9: 1–12.

Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy, Asthma Clin Immunol 2013; 9: 1–25.

Mujur, Amalia.M.P; Ismail SS. Tinea Kruris. J Med Prof - Acta Obstet Gynaecol Jpn 2019; 45: S-102.

Sahoo A, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. Indian Dermatol Online J 2016; 7: 77.

Sanggarwati SYDR, Wahyunitisari MR, Astari L, Ervianti E. Profile of Tinea Corporis and Tinea Cruris in Dermatovenereology Clinic of Tertiery Hospital: A Retrospective Study. Berk Ilmu Kesehat Kulit dan Kelamin 2021; 33: 34.

Downloads

Published

2023-05-12

Issue

Section

Articles